A2-Ai
Home
LeadershipBlogCareersGet in touch
Home
LeadershipBlogCareersGet in touch

Meg Gonsalves

Project Manager

Meg Gonsalves is a Project Manager in Business Development at A2-Ai. Leveraging her PhD in Neuroscience from Brown University, she blends scientific understanding with business operations to manage complex projects and support data-driven decisions that accelerate clients’ drug-development programs.

Categories

newsresearch spotlightsupdates

Tags

2025AgingAnnualCardiac SafetyClinical PharmacologyClinical ResearchClinical TrialsCross-SpeciesDrug DevelopmentEligibility CriteriaFDA GuidanceMetronidazole
RSS See all filters
newest
research spotlights

From Mouse to Horse to Human: What Metronidazole Can Teach Us About Translating Pharmacokinetics Across Species

January 20, 2026
updates

A Year of Science at A2-Ai: Reflections from 2025

December 26, 2025
news

New FDA Guidance on QTc Labeling: What Drug Developers Need to Know

December 8, 2025
research spotlights

Aligning Clinical Trials with Real-World Aging Trends

November 20, 2025

Links

Home Leadership Blog Careers Contact

Solutions

A2-Ai Cloud Alexandria PRISM Sage AI

Science Services

FDA Project Optimus Preclinical Support Clinical Pharmacology Pharmacometrics Education

Technology Services

Overview

Calculators

Exposure-Response Thresholds Multi-compartment PK Parameter Conversion

Resources

Attributions
A2-Ai

2723 S. State Street
Suite 310
Ann Arbor, MI 48104

© 2026 A2-Ai LLC. All rights reserved.